University of Michigan medtech spin-off Tangent Medical Technologies is now accepting commercial orders of the firm’s NovaCath IV catheter following four years of development. The Ann Arbor-based spin-off said it will begin deliveries of its catheter in the third quarter of the year, beginning next month. To date, Tangent has attracted $13.1m in venture funding…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
